Vaccination Schedules

Teh, Benjamin W

doi:10.1007/978-3-030-57317-1_7

Cited by 2 publications

(2 citation statements)

References 141 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Vaccination is an effective strategy to reduce the risk and burden of key infections and is recommended. Timing of vaccination is guided by consideration of patient‐, disease‐ and treatment‐related factors to ensure optimal response 49 . The evidence supporting vaccination recommendations is discussed in the full version of the guideline.…”

Section: Vaccinationmentioning

confidence: 99%

See 1 more Smart Citation

Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myeloma

Teh

Reynolds

Slavin

et al. 2023

Internal Medicine Journal

View full text Add to dashboard Cite

Infection remains a significant contributor to morbidity and mortality in patients with myeloma. This guideline was developed by a multidisciplinary group of clinicians who specialise in the management of patients with myeloma and infection from the medical and scientific advisory group from Myeloma Australia and the National Centre for Infections in Cancer. In addition to summarising the current epidemiology and risk factors for infection in patients with myeloma, this guideline provides recommendations that address three key areas in the prevention of infection: screening for latent infection, use of antimicrobial prophylaxis and immunoglobulin replacement and vaccination against leading respiratory infections (severe acute respiratory syndrome coronavirus 2, influenza and Streptococcus pneumoniae) and other preventable infections. This guideline provides a practical approach to the prevention of infection in patients with myeloma and harmonises the clinical approach to screening for infection, use of prophylaxis and vaccination to prevent infectious complications.

show abstract

Section: Vaccinationmentioning

confidence: 99%

“…Timing of vaccination is guided by consideration of patient-, disease-and treatment-related factors to ensure optimal response. 49 The evidence supporting vaccination recommendations is discussed in the full version of the guideline. Overall recommendations are summarised in Table 5.…”

Section: Vaccinationmentioning

confidence: 99%